$69.24
0.48%
NYSE, Sep 02, 10:00 pm CET
ISIN
US62548M1009
Symbol
CTEV

Claritev Stock price

$69.32
+30.01 76.34% 1M
+50.07 260.10% 6M
+54.54 369.01% YTD
+59.92 637.45% 1Y
-64.68 48.27% 3Y
-388.68 84.86% 5Y
-319.48 82.17% 10Y
-319.48 82.17% 20Y
NYSE, Closing price Tue, Sep 02 2025
+0.41 0.60%
ISIN
US62548M1009
Symbol
CTEV

Key metrics

Basic
Market capitalization
$1.1b
Enterprise Value
$5.7b
Net debt
$4.6b
Cash
$56.4m
Shares outstanding
16.5m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.2 | 1.2
EV/Sales
6.1 | 5.9
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
1.6%
Return on Equity
-1,958.8%
ROCE
1.3%
ROIC
1.1%
Debt/Equity
-116.0
Financials (TTM | estimate)
Revenue
$935.5m | $965.4m
EBITDA
$501.9m | $592.4m
EBIT
$62.9m | $68.0m
Net Income
$-663.4m | $-267.2m
Free Cash Flow
$-55.0m
Growth (TTM | estimate)
Revenue
-2.0% | 3.7%
EBITDA
-11.9% | 11.6%
EBIT
-56.0% | -31.2%
Net Income
43.4% | 83.8%
Free Cash Flow
-194.4%
Margin (TTM | estimate)
Gross
74.4%
EBITDA
53.7% | 61.4%
EBIT
6.7%
Net
-70.9% | -27.7%
Free Cash Flow
-5.9%
More
EPS
$-40.3
FCF per Share
$-3.3
Short interest
5.2%
Employees
-
Rev per Employee
-
Show more

Is Claritev a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Claritev Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Claritev forecast:

7x Buy
78%
2x Hold
22%

Analyst Opinions

9 Analysts have issued a Claritev forecast:

Buy
78%
Hold
22%

Financial data from Claritev

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
936 936
2% 2%
100%
- Direct Costs 239 239
2% 2%
26%
696 696
2% 2%
74%
- Selling and Administrative Expenses 194 194
37% 37%
21%
- Research and Development Expense - -
-
-
502 502
12% 12%
54%
- Depreciation and Amortization 439 439
3% 3%
47%
EBIT (Operating Income) EBIT 63 63
56% 56%
7%
Net Profit -663 -663
43% 43%
-71%

In millions USD.

Don't miss a Thing! We will send you all news about Claritev directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Claritev Stock News

Neutral
Business Wire
7 days ago
MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will participate in person at the following conferences in September 2025: 2025 Wells Fargo Healthcare Conference – Wednesday, Septemb...
Positive
The Motley Fool
28 days ago
Claritev (NYSE:CTEV), a healthcare data analytics and cost management company, reported its second quarter 2025 earnings on August 6, 2025. The standout news is revenue rising to $241.6 million (GAAP) in Q2 2025, which exceeded analyst estimates by $10.2 million (GAAP).
Neutral
Business Wire
28 days ago
MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Reports Second Quarter 2025 Results.
More Claritev News

Company Profile

MultiPlan Corp. provides healthcare cost management solutions. It uses technology-enabled provider network, negotiation, claim pricing and payment accuracy services as building blocks for medical and dental payors to customize the healthcare cost management programs. The company was founded in 1980 and is headquartered in New York, NY.

Head office United States
CEO Travis Dalton
Founded 1980
Website www.claritev.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today